Chemclin Diagnostics Co., Ltd. (688468.SS) SHH

6.59

-0.16(-2.37%)

Updated at June 02 03:00PM

Currency In CNY

Valuation

Market Cap2.96B
Enterprise Value3.04B
P/E Ratio76.05
PEG Ratio-1.14
Price/Sales Ratio8.14
Price/Book Ratio2.08
Enterprise/Revenue8.34
Enterprise/EBITDA36.29

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.12
Operating Margin0.13

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue330.38M
Revenue/Share0.72
Gross Profit198.38M
EBITDA112.73M
Net Income43.91M
Diluted EPS0.11

Balance Sheet

Total Cash388.7M
Total Cash/Share0.87
Total Debt181.64M
Total Debt/Equity0.13
Current Ratio4.77
Book Value Per Share3.17

Price History

52-Week Change-9.6
52-Week High9.12
52-Week Low6.52
Moving Average 50 Days7.24
Moving Average 200 Days7.68

Statistics

Average Volume3.28M
Shares Outstanding401.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.13
Trailing Annual Dividend Yield1.9
Payout Ratio1.37
Last Split FactorN/A
Last Split DateN/A